These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 9352133)
21. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847 [TBL] [Abstract][Full Text] [Related]
22. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction. Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002 [TBL] [Abstract][Full Text] [Related]
23. [Plasma levels of lipids, lipoproteins and apolipoproteins affected by endogenous testosterone]. Zhao S; Li X; Wang Z Hunan Yi Ke Da Xue Xue Bao; 1998; 23(3):299-301. PubMed ID: 10681765 [TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665 [TBL] [Abstract][Full Text] [Related]
34. Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosis. Stiel GM; Reblin T; Bührlen M; Lattermann A; Nienaber CA Coron Artery Dis; 1995 Apr; 6(4):347-50. PubMed ID: 7655720 [TBL] [Abstract][Full Text] [Related]
37. [Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke]. Mierzecki A; Bukowska H; Honczarenko K; Jastrzebska M; Millo B; Torbus-Lisiecka B Pol Arch Med Wewn; 2005 Feb; 113(2):119-29. PubMed ID: 16209232 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus. Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F Atherosclerosis; 2006 Oct; 188(2):455-61. PubMed ID: 16384561 [TBL] [Abstract][Full Text] [Related]
39. Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting. Ezhov MV; Safarova MS; Afanasieva OI; Kukharchuk VV; Pokrovsky SN Atherosclerosis; 2014 Aug; 235(2):477-82. PubMed ID: 24952151 [TBL] [Abstract][Full Text] [Related]
40. Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease. Frohlich J; Dobiásová M; Adler L; Francis M Physiol Res; 2004; 53(5):481-6. PubMed ID: 15479125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]